The current economic crisis has placed emphasis on Innovation Productivity like never before. Companies are facing the reality that the investments they make now in new product innovation MUST deliver!
By introducing a roadmapping process, organisations achieve a shared vision. It is the power of this collaborative perspective that reaps the greatest rewards.
Prodex Sponsors Robert Cooper Australian workshop series 2009
Our support of the Robert Cooper workshops has continued for the fifth consecutive year. Workshops were conducted in Melbourne and Sydney in March 2009 and covered material on ‘Strategy & Portfolio Management for New Products’ and ‘Winning at New Products’.
Monday 8 December 2008
Prodex Presents ‘Product Development Excellence Award’
Prodex Systems has sponsored the inaugural ‘Product Development Excellence Award’. This year’s winner from the Queensland University of Technology was Mark Sandstrom with the development of a Deep-brain stimulation surgery brace as part of his Graduate Diploma in Industrial Design research thesis.
Orrcon Steel gains edge through
Accolade
As the third largest
manufacturer in the Australian steel tube industry,
Orrcon faces tough competition from rivals; Smorgon and
One Steel. Forging ahead in business terms requires a
serious focus on all aspects of the game including a
world class approach to product and innovation
management...
Bostik deploys Accolade® to enhance Product Innovation
One of
the world’s leading manufacturers of adhesives and sealants, has implemented Sopheon’s
Accolade® system to support advancement of the company’s product innovation processes.
Ciba implements Accolade®
to focus innovation investment
The leading global manufacturer of specialty chemicals, is implementing Sopheon’s Accolade® to enhance the company’s capacity to govern its
innovation processes and focus resources on high-value product innovation projects. Accolade
has been made available to more than 900 individuals on cross-functional teams.
Recent signees include Novartis,
the world’s fifth-largest pharmaceutical company, Burger
King Corp., the second largest fast-food hamburger chain
in the world.
